European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.19% to 1,316.54 on the S&P Europe Select ADR Index, which is up approximately 1.2% for the week.
From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and medical device maker EDAP TMS (EDAP), which rose 3.6% and 2.6%, respectively. They were followed by internet browser company Opera (OPRA) and pharmaceutical company Ascendis Pharma (ASND), which were up 2.1% each.
The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and financial services company Banco Santander (SAN), which dropped 4.8% and 3.9%, respectively. They were followed by financial services companies ING (ING) and Banco Bilbao Vizcaya Argentaria (BBVA), which fell 2.7% and 2%, respectively.
From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Amarin (AMRN), which climbed 13% and 5.6% higher, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company AstraZeneca (AZN), which increased 5.5% and 2.9%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and TC Biopharm (TCBP), which lost 12% and 3.9%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were down 3.1% and 2.5%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。